Abstract

The discovery of Th17 cells has altered the landscape of immunology and led to numerous studies directed at defining the role that these cells play in inflammatory disorders. Graft-versus-host disease (GVHD) is one such prototypical inflammatory syndrome that has been thought to be primarily a Th1-mediated process. This review summarizes preclinical data derived from experimental murine models that have examined the role of IL-17 and Th17 cells in the biology of acute and chronic GVHD. The role of cytokines (IL-23, IL-6, IL-21) that are either secreted by Th17 cells or are important for the differentiation and/or maintenance of Th17 cells in the biology of experimental GVHD are also examined. Finally, a review of clinical studies that have utilized single nucleotide polymorphism differences between donor and recipient or the acquisition of patient blood and tissue samples to determine how IL-17 and IL-17-related cytokines impact GVHD severity is presented.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.